BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% | BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% |

Briefs

Anthropic Hires AI Welfare Officer — Institutional Recognition of Consciousness Risk

Analysis of Anthropic's decision to hire an AI welfare officer and its implications for AI consciousness governance.

Updated Mar 25, 2026

Google AI Research Introduces Titans Long-Context Architecture

Brief on Google's January 2025 release of the Titans architecture combining short-term and long-term memory.

Updated Mar 25, 2026

Landmark Consciousness Indicators Paper Published in Trends in Cognitive Sciences

Brief on the January 2026 publication of the most comprehensive AI consciousness assessment framework to date.

Updated Mar 25, 2026

Medtronic BrainSense Adaptive DBS Receives FDA Approval — First Closed-Loop BCI Therapy

Analysis of Medtronic's FDA approval for BrainSense Adaptive DBS, the first closed-loop deep brain stimulation therapy for Parkinson's disease.

Updated Mar 25, 2026

MIT Announces New Tool for Studying Consciousness Mechanisms

Brief on MIT's February 2026 announcement of a new tool for studying how consciousness emerges in biological neural networks.

Updated Mar 25, 2026

Ndea Combines Deep Learning with Program Synthesis for Novel AI

Brief on the January 2025 founding of Ndea by Keras creator François Chollet and Zapier co-founder Mike Knoop.

Updated Mar 25, 2026

Neuralink Announces UK Clinical Trial for Brain-Computer Interface

Brief on Neuralink's August 2025 announcement of a clinical trial in the United Kingdom.

Updated Mar 25, 2026

Neuralink Launches UAE-PRIME Clinical Trial in Abu Dhabi

Analysis of Neuralink's first international clinical trial outside North America, launched in Abu Dhabi in May 2025.

Updated Mar 25, 2026

Neuralink Receives FDA Breakthrough Device Designation for Speech Restoration

Analysis of the FDA's May 2025 Breakthrough Device designation for Neuralink's speech restoration BCI.

Updated Mar 25, 2026

Paradromics Receives FDA IDE Approval for Connexus BCI System

Brief on Paradromics' FDA Investigational Device Exemption approval for the Connect-One early feasibility study.

Updated Mar 25, 2026

Simons Foundation Launches Neural Computation Collaboration

Brief on the August 2025 launch of the Simons Collaboration on the Physics of Learning and Neural Computation.

Updated Mar 25, 2026

Synchron Announces Chiral — Foundation Model of Human Cognition

Intelligence brief on Synchron's March 2025 announcement of the Chiral cognitive foundation model roadmap.

Updated Mar 25, 2026
Layer 2 Intelligence

Access premium analysis for this section.

Subscribe →

Institutional Access

Coming Soon